British & American Investment Trust PLC
Interim Management Statement - 3 months to 30 September 2012
To the members of British & American Investment Trust PLC
This interim management statement has been produced solely to provide
additional information to shareholders as a body to meet the relevant
requirements of the UK Listing Authority's Disclosure and Transparency Rules.
It should not be relied upon by any other party or for any other purpose.
This interim management statement relates to the period from 1 July 2012 to 30
September 2012, and contains information that covers this period, and up to the
date of publication of this interim management statement, unless otherwise
specified.
Investment objective
To invest predominantly in investment trusts and other leading UK-quoted
companies to achieve a balance of income and growth.
Benchmark
FTSE All-Share Index and FTSE 100 Index.
Material developments
On 24 August 2012 the company reported its Half Year results to 30 June 2012.
An interim ordinary dividend of 2.7p is to be paid on 8 November 2012 to
shareholders on the register at 12 October 2012. A dividend of 1.75p per share
is to be paid to preference shareholders on 8 November 2012.
On 25 October 2012 a letter to shareholders was published regarding the
company's investment in Geron Corporation and the open letter sent by Biotime
Inc to Geron Corporation shareholders seeking to acquire Geron's stem cell
assets.
Twenty largest equity holdings at 30 September 2012 (group basis)
%
Geron Corporation 16.98
Rit Capital Partners plc 14.01
Prudential 12.16
Dunedin Income Growth 10.51
British Assets Trust 8.34
St James's Place International 6.92
Scottish & American Investment Company 4.08
Invesco Income Growth Trust 3.18
Alliance Trust 3.00
Royal & Sun Alliance Insurance Group 7.375% Cu. Irred.preference 2.25
shares £1
Rothschilds Continuation Finance - 9% Perp. Sub. Gtd. Loan Notes 2.06
F&C Asset Management - 6.75% FRN Sub. Bonds 2026 1.99
Shires Income 1.94
Merchants Trust 1.71
Earthport 1.14
Barclays Bank - 9% PIB Capital Bonds 0.99
St James's Place 0.85
Jupiter Income Trust 0.83
ADVFN 0.75
Emblaze Systems 0.73
Total 94.42
Sector allocation as at 30 September 2012 (group basis)
%
Investment Trusts 45.55
Biomedical - USA 15.86
Life Assurance 12.15
Unit Trusts 7.24
Software and computer services 1.75
Other Financial 0.70
Leisure and hotels 0.44
Telecommunications 0.42
Property 0.24
Bank retail 0.16
Biotechnology 0.12
Media 0.08
Pharmaceuticals 0.07
Financial services 0.07
Support services 0.03
Overseas 0.01
Derivatives - traded options 6.31
Fixed Interest Stocks excluding 3.79
Preference
Preference 2.58
Property Units 1.26
Permanent Interest Bearing 1.08
Fixed Interest Stocks (unquoted) 0.09
Total 100.00
Key facts
Performance
As at As at As at As at As at
30 30 30 30 30
September September September September September
2012 2012 2011 2009 2007
Year end to 1 year 3 years 5 years
date
Total assets 24,545
(000)
Short term £nil
borrowings
Actual gearing nil %
70.1
NAV (p)
2,998.86
FTSE All-Share
72.0 7.5% 4.3% -20.0% -35.1%
Share price (p)
2.7% -5.3% -6.3% -11.8%
Premium/
(discount)
10.28% 10.43% 7.33% 5.59%
Dividend yield
1.95%
Total expense
ratio
(year ended 31/12
/11)
1 year 3 years 5 years
Value of £100 116.0 105.4 99.9
invested
(dividends
reinvested)
FTSE ALL-Share 113.0 113.8 91.4
Total Return; Net Income Reinvested, GBP
Source: Walker Crips Stockbrokers Limited and Fundamental Data Limited.
The Board is not aware of any significant events or transactions which have
occurred between 30 September 2012 and the date of publication of this interim
management statement which would have a material impact on the financial
position of the Company. For latest performance information, please refer to
the Company's website, www.baitgroup.co.uk.
For British & American Investment Trust PLC
5 November 2012
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.